Focus on HIV Care

SORT BY:     Most Recent      Most Viewed
  • February 1, 2007

    Compared with patients given placebo, women receiving single-dose nevirapine (Viramune—Boehringer Ingelheim) during labor and delivery to prevent perinatal transmission of HIV-1 were more...

  • November 1, 2006

    An experimental genetic test for HLA-B*5701 may distinguish patients who are predisposed to developing a hypersensitivity reaction to abacavir (Ziagen—GlaxoSmithKline). Currently...

  • September 1, 2006

    The highlighted topics at the XVI International AIDS Conference held in Toronto in August 2006 included prevention, future treatment alternatives, and the possibility of pre-exposure prophylaxis...

  • August 1, 2006

    Highly active antiretroviral therapy (HAART)—three or more antiretrovirals including either a protease inhibitor (PI) or nonnucleoside reductase inhibitor (NNRTI)—increased systolic or diastolic...

  • April 1, 2006

    Antiretroviral regimens are complicated and subject to a host of influences, and to increase the likelihood of achieving therapeutic responses, researchers are studying both pharmacogenetics and...